ATG16L1 Human shRNA Plasmid Kit (Locus ID 55054)

CAT#: TG306516

ATG16L1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided


USD 883.00

In Stock*

Size
    • 1 kit

Product Images

Frequently bought together (2)
TurboFectin Transfection Reagent (1 mL in 1 vial)
    • 1 ml in 1 vial

USD 507.00


ATG16L1 mouse monoclonal antibody,clone OTI5A2
    • 100 ul

USD 447.00

Other products for "ATG16L1"

Specifications

Product Data
Locus ID 55054
Synonyms APG16L; ATG16A; ATG16L; IBD10; WDR30
Vector pGFP-V-RS
E. coli Selection Kanamycin
Mammalian Cell Selection Puromycin
Format Retroviral plasmids
Kit Components ATG16L1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 55054). 5µg purified plasmid DNA per construct
29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free.
RefSeq BC013411, NM_001190266, NM_001190267, NM_017974, NM_030803, NM_198890, NM_017974.1, NM_017974.2, NM_017974.3, NM_030803.1, NM_030803.2, NM_030803.3, NM_030803.4, NM_030803.5, NM_030803.6, NM_198890.1, NM_198890.2, NM_001190267.1, NM_001190266.1, BC000061, BC006253, BC071846, BC117337, BC143900, NM_001363742, NM_001190267.2, NM_030803.7, NM_001190266.2, NM_017974.4
UniProt ID Q676U5
Summary The protein encoded by this gene is part of a large protein complex that is necessary for autophagy, the major process by which intracellular components are targeted to lysosomes for degradation. Defects in this gene are a cause of susceptibility to inflammatory bowel disease type 10 (IBD10). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jun 2010]
shRNA Design These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.

For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.